{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:38:39Z","timestamp":1771929519740,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de R\u00e9adaptation et de M\u00e9decine Physique"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.annrmp.2007.03.019","type":"journal-article","created":{"date-parts":[[2007,4,21]],"date-time":"2007-04-21T07:10:21Z","timestamp":1177139421000},"page":"651-660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Efficacit\u00e9 des\u00a0injections intrad\u00e9trusoriennes r\u00e9p\u00e9t\u00e9es de\u00a0toxine A dans\u00a0l'hyperactivit\u00e9 v\u00e9sicale d'origine neurologique"],"prefix":"10.1016","volume":"50","author":[{"given":"A.","family":"Chenet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Perrouin-Verbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Le Normand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-J.","family":"Labat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Brunel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lefort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-F.","family":"Math\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annrmp.2007.03.019_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardization of terminology of lower urinary tract function: Report of the standardization sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol. Urodyn."},{"issue":"6","key":"10.1016\/j.annrmp.2007.03.019_bib2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00002060-199312000-00005","article-title":"Botulinum toxin for the treatment of spasticity in multiple sclerosis. New observations","volume":"72","author":"Borg-Stein","year":"1993","journal-title":"Am. J. Phys. Med. Rehabil."},{"issue":"suppl","key":"10.1016\/j.annrmp.2007.03.019_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0090-4295(99)00492-6","article-title":"Muscarinic receptor antagonists in the treatment of overactive bladder","volume":"55","author":"Chapple","year":"2000","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.annrmp.2007.03.019_bib4","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.eururo.2006.01.025","article-title":"Histologic features in the urinary bladder wall affected from neurogenic overactivity - a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A","volume":"50","author":"Comperat","year":"2006","journal-title":"Eur. Urol."},{"issue":"7","key":"10.1016\/j.annrmp.2007.03.019_bib5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.sc.3101736","article-title":"Adverse events after botulinum A toxin injection for neurogenic voiding disorders","volume":"43","author":"De Laet","year":"2005","journal-title":"Spinal Cord"},{"issue":"6","key":"10.1016\/j.annrmp.2007.03.019_bib6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0168-6054(03)00113-2","article-title":"Effet de la toxine A intrad\u00e9trusorienne pour le traitement de l'hyperactivit\u00e9 v\u00e9sicale d'origine neurologique","volume":"46","author":"Denys","year":"2003","journal-title":"Ann. Readapt. Med. Phys."},{"issue":"9","key":"10.1016\/j.annrmp.2007.03.019_bib7","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0003-9993(03)00202-8","article-title":"Use of botulinum toxin type B for the treatment of detrusor hyperreflexia in a patient with multiple sclerosis: a case report","volume":"84","author":"Dykstra","year":"2003","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"5","key":"10.1016\/j.annrmp.2007.03.019_bib8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","article-title":"Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence","volume":"47","author":"Grosse","year":"2005","journal-title":"Eur. Urol."},{"issue":"6","key":"10.1016\/j.annrmp.2007.03.019_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.eururo.2004.07.011","article-title":"Lack of ultrastrutural detrusor changes following endoscopic injection of botulinum toxin type A in overactive neurogenic bladder","volume":"46","author":"Haferkamp","year":"2004","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.annrmp.2007.03.019_bib10","first-page":"2543","article-title":"Efficacy of botulinum-A toxin in adults with neurogenic overactive bladder: initial results","volume":"12","author":"Hajebrahimi","year":"2005","journal-title":"Can. J. Urol."},{"issue":"Suppl 1","key":"10.1016\/j.annrmp.2007.03.019_bib11","doi-asserted-by":"crossref","first-page":"I16","DOI":"10.1007\/s00415-006-1104-0","article-title":"Botulinum toxin in multiple sclerosis","volume":"253","author":"Jost","year":"2006","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.annrmp.2007.03.019_bib12","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.urology.2006.08.1069","article-title":"Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity","volume":"68","author":"Karsenty","year":"2006","journal-title":"Urology"},{"issue":"11","key":"10.1016\/j.annrmp.2007.03.019_bib13","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.apmr.2005.06.008","article-title":"Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions","volume":"86","author":"Klaphajone","year":"2005","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"5","key":"10.1016\/j.annrmp.2007.03.019_bib14","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","article-title":"Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents","volume":"63","author":"Kuo","year":"2004","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.annrmp.2007.03.019_bib15","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.eururo.2005.12.015","article-title":"Successful treatment with intradetrusor botulinum-A toxin for urethral urinary leakage (catheter bypassing) in patients with end-staged multiple sclerosis and indwelling suprapubic catheters","volume":"50","author":"Lekka","year":"2006","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.annrmp.2007.03.019_bib16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.sc.3100432","article-title":"International Standards for Neurological and Functional Classification of Spinal Cord Injury. American Spinal Injury Association","volume":"35","author":"Maynard","year":"1997","journal-title":"Spinal Cord"},{"issue":"4","key":"10.1016\/j.annrmp.2007.03.019_bib17","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","article-title":"European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity","volume":"45","author":"Reitz","year":"2004","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.annrmp.2007.03.019_bib18","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.urology.2005.05.054","article-title":"Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity","volume":"66","author":"Schulte-Baukloh","year":"2005","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.annrmp.2007.03.019_bib19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/nau.20153","article-title":"Efficacy of Botulinum-A toxin bladder injections fot the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis","volume":"25","author":"Schulte-Baukloh","year":"2006","journal-title":"Neurourol. Urodyn."},{"issue":"1","key":"10.1016\/j.annrmp.2007.03.019_bib20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","article-title":"Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study","volume":"174","author":"Schurch","year":"2005","journal-title":"J. Urol."},{"issue":"3 Pt 1","key":"10.1016\/j.annrmp.2007.03.019_bib21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J. Urol."},{"issue":"6 Pt 1","key":"10.1016\/j.annrmp.2007.03.019_bib22","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1097\/01.ju.0000127725.48479.89","article-title":"Emerging role of botulinum toxin in the management of voiding dysfunction","volume":"171","author":"Smith","year":"2004","journal-title":"J. Urol."}],"container-title":["Annales de R\u00e9adaptation et de M\u00e9decine Physique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168605407000906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168605407000906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T18:58:19Z","timestamp":1759172299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168605407000906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0168605407000906"],"URL":"https:\/\/doi.org\/10.1016\/j.annrmp.2007.03.019","relation":{},"ISSN":["0168-6054"],"issn-type":[{"value":"0168-6054","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacit\u00e9 des\u00a0injections intrad\u00e9trusoriennes r\u00e9p\u00e9t\u00e9es de\u00a0toxine A dans\u00a0l'hyperactivit\u00e9 v\u00e9sicale d'origine neurologique","name":"articletitle","label":"Article Title"},{"value":"Annales de R\u00e9adaptation et de M\u00e9decine Physique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annrmp.2007.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}